Wie hoch ist der Preis für Anteris Technologies Global Corp. (AVR)

Preis für Anteris Technologies Global Corp. (AVR) ist $8.88

Wie hoch ist die Marktkapitalisierung für Anteris Technologies Global Corp. (AVR)

Marktkapitalisierung für Anteris Technologies Global Corp. (AVR) ist $863.29M

Anteris Technologies Global Corp. (AVR) Umsatz

Anteris Technologies Global Corp. is a structural heart innovator dedicated to discovering, developing, and bringing to market medical devices that enhance the well-being of patients grappling with aortic stenosis. The company's premier offering is the DurAVR transcatheter heart valve system, a pioneering transcatheter aortic valve engineered to treat aortic stenosis by precisely emulating the performance of a healthy human aortic valve. Beyond this, Anteris develops ADAPT anti-calcification tissue, a unique preparation that transforms xenograft tissue into robust bioscaffolds. These bioscaffolds are designed to simulate human tissue for various surgical repairs, notably in aortic valve replacement. Additionally, the ComASUR delivery system, a physician-designed balloon-expandable apparatus, features a reinforced, steerable catheter. This allows for highly accurate navigation through cardiac anatomy in a controlled manner, thereby mitigating potential damage to the aorta. Founded in 1999, Anteris Technologies Global Corp. operates out of Toowong, Australia.

Jahr	Umsatz	ändert
Nicht genügend Daten für die angegebenen Daten.

Jahr

Umsatz

ändert

Nicht genügend Daten für die angegebenen Daten.

Unternehmen	Umsatz	Umsatzunterschied	Land
Abbott Laboratories ABT.US	$46.59B	-	US
Stryker Corporation SYK.US	$25.84B	-	US
Medtronic plc MDT.US	$35.48B	-	IE
Boston Scientific Corporation BSX.US	$21.00B	-	US
Siemens Healthineers AG SHL.DE	-	-	DE

Unternehmen

Umsatz

Umsatzunterschied

Land